QQ客服 官方微博 反馈留言

浏览/检索结果: 共19条，第1-10条 帮助 限定条件 专题：合肥物质科学研究院    第一署名单位    第一作者单位    通讯作者单位     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择发表日期升序发表日期降序提交时间升序提交时间降序题名升序题名降序作者升序作者降序 Genomic characterization reveals distinct mutation landscapes and therapeutic implications in neuroendocrine carcinomas of the gastrointestinal tract 期刊论文 CANCER COMMUNICATIONS, 2022 作者:  Wu, Huanwen;  Yu, Zicheng;  Liu, Yueping;  Guo, Lei;  Teng, Lianghong 收藏  |  浏览/下载：20/0  |  提交时间：2022/12/22 Neuroendocrine carcinomas  Gastrointestinal tract  Genomic characterization  Heterogeneity  Therapeutic implications   Correlation of PD-L1 Expression with Clinicopathological and Genomic Features in Chinese Non-Small-Cell Lung Cancer 期刊论文 JOURNAL OF ONCOLOGY, 2022, 卷号: 2022 作者:  Li, Yue;  Li, Chong;  Jiang, Ya;  Han, Xue;  Liu, Sisi 收藏  |  浏览/下载：12/0  |  提交时间：2022/12/23 p53 Immunohistochemistry Patterns Are Surrogate Biomarkers for TP53 Mutations in Gastrointestinal Neuroendocrine Neoplasms 期刊论文 GASTROENTEROLOGY RESEARCH AND PRACTICE, 2021, 卷号: 2021 作者:  Li, Junjie;  Wang, Jing;  Su, Dan;  Nie, Xiu;  Liu, Yueping 收藏  |  浏览/下载：46/0  |  提交时间：2022/02/14 TP53 Mutation Infers a Poor Prognosis and Is Correlated to Immunocytes Infiltration in Breast Cancer 期刊论文 FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 卷号: 9 作者:  Zhang, Ziwen;  Hao, Ran;  Guo, Qiusheng;  Zhang, Sheyu;  Wang, Xiaojia 收藏  |  浏览/下载：32/0  |  提交时间：2022/01/10 TP53  mutation  breast cancer  immunocytes infiltration  prognosis   Genomic alterations in biliary tract cancer predict prognosis and immunotherapy outcomes 期刊论文 JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 卷号: 9 作者:  Chen, Xiaofeng;  Wang, Deqiang;  Liu, Jing;  Qiu, Jingrong;  Zhou, Jun 收藏  |  浏览/下载：32/0  |  提交时间：2022/01/10 immunotherapy  tumor microenvironment  biomarkers  tumor  genetic markers   Molecular and Clinical Characteristics of Primary Pulmonary Lymphoepithelioma-Like Carcinoma 期刊论文 FRONTIERS IN MOLECULAR BIOSCIENCES, 2021, 卷号: 8 作者:  Fan, Ying;  Shan, Qianyun;  Gong, Jiali;  Qin, Jing;  Lu, Hongyang 收藏  |  浏览/下载：43/0  |  提交时间：2022/01/10 PPLELC  clinical characteristics  molecular characteristics  immunotherapy  PD-L1  TMB   Profiling Receptor Tyrosine Kinase Fusions in Chinese Breast Cancers 期刊论文 FRONTIERS IN ONCOLOGY, 2021, 卷号: 11 作者:  Tao, Zhonghua;  Liu, Jianxia;  Li, Ting;  Xu, Hong;  Chen, Kai 收藏  |  浏览/下载：30/0  |  提交时间：2022/01/10 receptor tyrosine kinase  gene fusion  genomic rearrangments  breast cancer  next-generation sequencing   High chromosome instability identified by low-pass whole-genome sequencing assay is associated with TP53 copy loss and worse prognosis in BRCA1 germline mutation breast cancer 期刊论文 BREAST CANCER, 2021 作者:  Zhu, Liang;  Pan, Jia-Ni;  Qian, Ziliang;  Ye, Wei-Wu;  Wang, Xiao-Jia 收藏  |  浏览/下载：23/0  |  提交时间：2021/09/06 CIN  TP53  BRCA1  LPWGS  Breast cancer   The genomic landscape of young and old lung cancer patients highlights age-dependent mutation frequencies and clinical actionability in young patients 期刊论文 INTERNATIONAL JOURNAL OF CANCER, 2021 作者:  Cai, Lei;  Chen, Yong;  Tong, Xiaoling;  Wu, Xue;  Bao, Hua 收藏  |  浏览/下载：60/0  |  提交时间：2021/06/15 EGFR  ERBB2  gene fusions  tyrosine kinase inhibitors  young lung cancer patients   Efficacy and Resistance of Afatinib in Chinese Non-Small Cell Lung Cancer Patients With HER2 Alterations: A Multicenter Retrospective Study 期刊论文 FRONTIERS IN ONCOLOGY, 2021, 卷号: 11 作者:  Song, Zhengbo;  Lv, Dongqing;  Chen, Shiqing;  Huang, Jianhui;  Wang, Liping 收藏  |  浏览/下载：15/0  |  提交时间：2021/06/21 non-small cell lung cancer (NSCLC)  HER2  afatinib  efficacy  resistance